Published

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology
Date: 2020-11-01
Source: PubMed
DOI: 10.1038/s41386-020-0718-8
PubMed: 32446245

Authors

Mason NL Kuypers KPC Müller F Reckweg J Tse DHY Toennes SW Hutten NRPW Jansen JFA Stiers P Feilding A Ramaekers JG

Watch author

Derived topics and classifications

psilocybin Depression Brain Imaging Mechanism of Action Aging Clinical Trial Animal Study Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 8 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats2026-07-01 Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons2026-03-27 Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors2026-03-26 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects2022-12-01 Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice2022-02-23 Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience2021-09-01 Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin.2020-11-01

Related papers

The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14 Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot StudyClinicalTrials.gov · 2026-08-10 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized TrialClinicalTrials.gov · 2026-08-13 Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use DisorderClinicalTrials.gov · 2026-08-12 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic TherapyClinicalTrials.gov · 2026-08-06